Starting March 21, McDonald's will expand its partnership with Krispy Kreme to approximately 160 locations across Louisville, Lexington, and the surrounding area. 

The initiative was first launched in October at nine locations in Kentucky. 

This expanded market test is designed to test customer demand for the popular sweet treats, which now includes three varieties: Krispy Kreme's Original Glazed Doughnut, Chocolate Iced with Sprinkles Doughnut, and the Raspberry Filled Doughnut.  

"McDonald’s is always looking for ways to give our fans more of what they crave, and we often conduct tests to inform future menu decisions," the company said in a press release. "This small-scale test will help us understand how offering new bakery items like Krispy Kreme could impact operations in our restaurants."

McDonald's has so far benefited from customers trading down due to inflation. The company recently beat Wall Street estimates for its quarterly earnings and revenue, in large part because it was able to raise prices without scaring off customers. 

Krispy Kreme, likewise, has reported strong earnings on the back of price hikes. It is also increasingly relying on distribution partnerships to reach customers such as through Walgreens, Acme, and ShopRite. 

If the partnership with McDonald's continues to grow, it could become a major source of revenue for the growing doughnut business. 

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More